Cargando…
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial
BACKGROUND: Standard insulin infusion sets (IISs) are to be replaced every 2 to 3 days to avoid complications and diabetic ketosis due to set failure. This pivotal trial evaluated the safety and performance of a new extended-wear infusion set (EIS) when used for 7 days by adults with type 1 diabetes...
Autores principales: | Brazg, Ron, Garg, Satish K., Bhargava, Anuj, Thrasher, James R., Latif, Kashif, Bode, Bruce W., Bailey, Timothy S., Horowitz, Barry S., Cavale, Arvind, Kudva, Yogish C., Kaiserman, Kevin B., Grunberger, George, Reed, John Chip, Chattaraj, Sarnath, Zhang, Gina, Shin, John, Chen, Vivian, Lee, Scott W., Cordero, Toni L., Rhinehart, Andrew S., Vigersky, Robert A., Buckingham, Bruce A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353978/ https://www.ncbi.nlm.nih.gov/pubmed/35263188 http://dx.doi.org/10.1089/dia.2021.0540 |
Ejemplares similares
-
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes
por: Carlson, Anders L., et al.
Publicado: (2022) -
Continuous Glucose Monitoring Enables the Detection of Losses in Infusion Set Actuation (LISAs)
por: Howsmon, Daniel P., et al.
Publicado: (2017) -
Clinical and Safety Evaluation of Continuously Infused Ceftolozane/Tazobactam in the Outpatient Setting
por: Jones, Bruce M, et al.
Publicado: (2020) -
How fast can glucose be infused in the perioperative setting?
por: Hahn, Robert G.
Publicado: (2016) -
Insulin Infusion Set Use: European Perspectives and Recommendations
por: Deiss, Dorothee, et al.
Publicado: (2016)